HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

5-aminolevulinic acid fluorescence guided surgery for resection of cystic meningioma with bone invasion.

Abstract
Meningiomas have a 5 year recurrence rate of 8%. Histological grade and extent of resection are the two main prognostic factors. Cystic meningiomas represent between 2 and 4% of meningiomas, and the complete resection rate in these cases is 62.7%. 5-ALA has been shown to be useful in detecting tumour remnants that could go unnoticed by the conventional microsurgical technique, thereby achieving more complete resections. We present the case of a 66-year-old patient with a frontal convexity meningioma, presenting with a cystic component and bone invasion, who was treated using 5-ALA fluorescence-guided surgery. Fluorescence emission from the tumour tissue allowed the areas of bone invasion and the cystic wall to be identified, achieving complete resection.
AuthorsRafael García Moreno, Hyaissa Ippolito Bastidas, Ignacio Fernández Portales, Alejandro Rubio Fernández, María Hidalgo Llorca, José Manuel Cabezudo Artero
JournalBritish journal of neurosurgery (Br J Neurosurg) Vol. 37 Issue 5 Pg. 1223-1227 (Oct 2023) ISSN: 1360-046X [Electronic] England
PMID33095079 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Aminolevulinic Acid
  • 5-amino levulinic acid
Topics
  • Humans
  • Aged
  • Meningioma (diagnostic imaging, surgery, pathology)
  • Aminolevulinic Acid
  • Meningeal Neoplasms (diagnostic imaging, surgery, pathology)
  • Fluorescence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: